Posted on: January 30, 2020 Posted by: admin Comments: 0

ANCOBON PRESCRIBING INFORMATION PDF

Package Insert-Flucytosine * Ancobon® is a The appropriate approved prescribing information should be consulted. Images. Group: antifungal. Capsule, mg [EDL] Solution for injection, g in ml [ EDL]. General information. Flucytosine is a fluorinated pyrimidine, non-antibiotic . Related Drug Information Flucytosine must be given with extreme caution to patients with bone marrow suppression. of America (IDSA) recommends 25 mg /kg/dose PO 4 times daily in combination with a lipid amphotericin B product.

Author: Mauran Voodookus
Country: Great Britain
Language: English (Spanish)
Genre: Environment
Published (Last): 19 September 2005
Pages: 405
PDF File Size: 4.12 Mb
ePub File Size: 16.43 Mb
ISBN: 510-8-26915-324-7
Downloads: 79069
Price: Free* [*Free Regsitration Required]
Uploader: Muramar

The risk or severity of adverse effects can be increased when Clofarabine is combined with Flucytosine. Induction therapy is usually for 2 weeks; however, the duration of initial therapy depends on site and severity of infection, clinical response, and underlying risk factors.

Flucytosine – Drugs Prescribing Information

The risk or severity of adverse effects can be increased when Chlorambucil is combined with Flucytosine. Triflusal The risk or severity of bleeding can be increased when Triflusal is combined with Flucytosine. Ciclesonide The risk or severity of adverse effects can be increased when Flucytosine is combined with Ciclesonide. The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Flucytosine.

Rabies virus inactivated antigen, B The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Flucytosine. Tocilizumab The risk or severity of adverse effects can be increased when Flucytosine is combined with Tocilizumab.

Flucytosine

The risk or severity of adverse effects can be increased when Flucytosine is combined with Cloprednol. There is contradictory evidence concerning a drug interaction between Ancotil and cytarabine. Aldosterone The risk or severity of adverse effects can be increased when Flucytosine is combined with Aldosterone. The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Flucytosine.

  DISCONNECTEUR SOCLA BA 2860 PDF

Its side effects are also similar to those observed with anticancer drugs. Eculizumab The risk or severity of adverse effects can be increased when Flucytosine is combined with Eculizumab.

Ardeparin The risk or severity of bleeding can be increased when Ardeparin is combined with Flucytosine. Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Flucytosine.

Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Flucytosine. Bendroflumethiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Flucytosine.

The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Flucytosine. Dactinomycin The risk or severity of adverse effects can be increased when Dactinomycin is combined with Flucytosine.

ANCOBON Dosage & Rx Info | Uses, Side Effects – MPR

Recipient’s Email Separate multiple email address with a comma Please enter valid preacribing address Recipient’s email is required. Patients should avoid use of this probiotic yeast until the fungal or yeast infection is completely treated.

Hydroflumethiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Flucytosine.

The risk or severity of adverse effects can be increased when Penicillamine is combined with Flucytosine. The risk or severity of prsecribing effects can be increased when Flucytosine is combined with Bendamustine.

  HANS KMOCH PDF

The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Flucytosine. Interferon alfa-n3 The risk or severity of adverse effects can be increased when Interferon ancoobn is combined with Flucytosine. Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Flucytosine.

PDR Search

The informayion or severity of adverse effects can be increased when Flucytosine is combined with Ponatinib. The risk or severity of adverse effects can be increased when Azacitidine is combined with Flucytosine. Food and antacids decrease the absorption rate, but the total extent absorbed is not relevantly affected. The risk or severity of adverse effects can be increased when Flucytosine is combined with omega interferon. Vincristine The risk or severity of prescribiny effects prescribjng be increased when Vincristine is combined with Flucytosine.

Only a small proportion of flucytosine is metabolised. The risk or severity of adverse effects can be increased when Tretinoin is combined with Flucytosine. Ancotil should not be used in patients with impaired renal function in the absence of facilities for monitoring blood levels of the drug.

Ifosfamide The risk or severity of adverse effects can be increased when Flucytosine is combined with Ifosfamide. Brinase The risk or severity of bleeding can be increased when Prescribiing is combined with Flucytosine. In cases where renal impairment is present the dose interval should be extended as with adults and children.

Categories:

Leave a Comment